CRP and systemic inflammatory response syndrome: Surprisingly, participants who received only two vials of AAV were those who still presented with a systemic inflammatory response syndrome 30 d after treatment, i.e., an inflammatory response based on increased CRP levels (4 participants), fibrinogen levels (3 participants), and leukocyte count (1 participant) (4, 54–59).